A citation-based method for searching scientific literature

Krishnath M Jayatilleke, Mark D Hulett. J Transl Med 2020
Times Cited: 10







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Heparanase: A Challenging Cancer Drug Target.
Deirdre R Coombe, Neha S Gandhi. Front Oncol 2019
17
50

Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
Silvia Rivara, Ferdinando M Milazzo, Giuseppe Giannini. Future Med Chem 2016
97
50

A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours.
Keith Dredge, Todd V Brennan, Edward Hammond, Jason D Lickliter, Liwen Lin, Darryn Bampton, Paul Handley, Fleur Lankesheer, Glynn Morrish, Yiping Yang,[...]. Br J Cancer 2018
39
40

Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy.
Monica Galli, Manik Chatterjee, Mariella Grasso, Giorgina Specchia, Hila Magen, Hermann Einsele, Ivana Celeghini, Paola Barbieri, David Paoletti, Silvia Pace,[...]. Haematologica 2018
55
40

Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.
Israel Vlodavsky, Miriam Gross-Cohen, Marina Weissmann, Neta Ilan, Ralph D Sanderson. Trends Biochem Sci 2018
73
40

Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, Lilach Gutter-Kapon, Michael Elkin, Ralph D Sanderson, Neta Ilan. Drug Resist Updat 2016
111
40

Human heparanase nuclear localization and enzymatic activity.
Shay Y Schubert, Neta Ilan, Moran Shushy, Ofer Ben-Izhak, Israel Vlodavsky, Orit Goldshmidt. Lab Invest 2004
84
30

Nuclear translocation of heparan sulfate proteoglycans and their functional significance.
Ilona Kovalszky, Anders Hjerpe, Katalin Dobra. Biochim Biophys Acta 2014
28
30

Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Ralph D Sanderson, Michael Elkin, Alan C Rapraeger, Neta Ilan, Israel Vlodavsky. FEBS J 2017
116
30

SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Joseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Sergio Penco, Claudio Pisano, Paolo Carminati, Monica Tortoreto,[...]. Clin Cancer Res 2011
162
30

The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
Marina Weissmann, Udayan Bhattacharya, Sari Feld, Edward Hammond, Neta Ilan, Israel Vlodavsky. Matrix Biol 2019
27
30

Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer.
Nourhan Hassan, Burkhard Greve, Nancy A Espinoza-Sánchez, Martin Götte. Cell Signal 2021
14
30

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
Hui Zhang, Chenxin Xu, Chen Shi, Junying Zhang, Ting Qian, Zhuo Wang, Rong Ma, Jianzhong Wu, Feng Jiang, Jifeng Feng. J Transl Med 2021
4
75

Heparanase-The Message Comes in Different Flavors.
Neta Ilan, Udayan Bhattacharya, Uri Barash, Ilanit Boyango, Yifat Yanku, Miri Gross-Cohen, Israel Vlodavsky. Adv Exp Med Biol 2020
9
33

Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Ilana Doweck, Nir Feibish. Adv Exp Med Biol 2020
6
50

Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.
Miriam Gross-Cohen, Sari Feld, Inna Naroditsky, Ofer Nativ, Neta Ilan, Israel Vlodavsky. Oncotarget 2016
15
30

Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
Miriam Gross-Cohen, Sari Feld, Ilana Doweck, Gera Neufeld, Peleg Hasson, Gil Arvatz, Uri Barash, Inna Naroditsky, Neta Ilan, Israel Vlodavsky. Cancer Res 2016
22
30

Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
Flonia Levy-Adam, Sari Feld, Victoria Cohen-Kaplan, Anna Shteingauz, Miriam Gross, Gil Arvatz, Inna Naroditsky, Neta Ilan, Ilana Doweck, Israel Vlodavsky. J Biol Chem 2010
78
30

Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.
Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-Ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D Sanderson, Yuval Shaked,[...]. Cancer Res 2020
13
30

The Role of Glypicans in Cancer Progression and Therapy.
Nan Li, Madeline R Spetz, Mitchell Ho. J Histochem Cytochem 2020
7
28

Heparanase, Heparan Sulfate and Viral Infection.
Alex Agelidis, Deepak Shukla. Adv Exp Med Biol 2020
11
20

PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
Bo-Yi Liao, Zheng Wang, Jie Hu, Wei-Feng Liu, Zao-Zhuo Shen, Xin Zhang, Lei Yu, Jia Fan, Jian Zhou. Tumour Biol 2016
23
20

Forty Years of Basic and Translational Heparanase Research.
Israel Vlodavsky, Neta Ilan, Ralph D Sanderson. Adv Exp Med Biol 2020
17
20

Shed proteoglycans in tumor stroma.
Zoi Piperigkou, Benedikt Mohr, Nikos Karamanos, Martin Götte. Cell Tissue Res 2016
44
20


Heparan sulfate in the nucleus and its control of cellular functions.
Mark D Stewart, Ralph D Sanderson. Matrix Biol 2014
59
20

Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.
Chakrabhavi Dhananjaya Mohan, Swetha Hari, Habbanakuppe D Preetham, Shobith Rangappa, Uri Barash, Neta Ilan, S Chandra Nayak, Vijai K Gupta, Basappa, Israel Vlodavsky,[...]. iScience 2019
28
20

Glycosaminoglycan-Protein Interactions: The First Draft of the Glycosaminoglycan Interactome.
Sylvain D Vallet, Olivier Clerc, Sylvie Ricard-Blum. J Histochem Cytochem 2021
17
20

Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan.
Zehra Elgundi, Michael Papanicolaou, Gretel Major, Thomas R Cox, James Melrose, John M Whitelock, Brooke L Farrugia. Front Oncol 2020
17
20

HS and Inflammation: A Potential Playground for the Sulfs?
Rana El Masri, Yoann Crétinon, Evelyne Gout, Romain R Vivès. Front Immunol 2020
6
33


Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
Daniele Pala, Silvia Rivara, Marco Mor, Ferdinando Maria Milazzo, Giuseppe Roscilli, Emiliano Pavoni, Giuseppe Giannini. Glycobiology 2016
46
20


Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Valeria Cagno, Eirini D Tseligka, Samuel T Jones, Caroline Tapparel. Viruses 2019
87
20

Glycosaminoglycanomics: where we are.
Sylvie Ricard-Blum, Frédérique Lisacek. Glycoconj J 2017
22
20

Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer.
John R Couchman, Hinke Multhaupt, Ralph D Sanderson. F1000Res 2016
25
20

PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Vito Ferro, Keith Dredge, Ligong Liu, Edward Hammond, Ian Bytheway, Caiping Li, Ken Johnstone, Tomislav Karoli, Kat Davis, Elizabeth Copeman,[...]. Semin Thromb Hemost 2007
114
20


Heparan sulfate as a regulator of inflammation and immunity.
Laura E Collins, Linda Troeberg. J Leukoc Biol 2019
33
20

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Neta Ilan, Michael Elkin, Israel Vlodavsky. Int J Biochem Cell Biol 2006
401
20

Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.
Vishnu C Ramani, Israel Vlodavsky, Mary Ng, Yi Zhang, Paola Barbieri, Alessandro Noseda, Ralph D Sanderson. Matrix Biol 2016
55
20

Demystifying heparan sulfate-protein interactions.
Ding Xu, Jeffrey D Esko. Annu Rev Biochem 2014
373
20

Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.
Alyce J Mayfosh, Nikola Baschuk, Mark D Hulett. Front Oncol 2019
14
20

The GAGOme: a cell-based library of displayed glycosaminoglycans.
Yen-Hsi Chen, Yoshiki Narimatsu, Thomas M Clausen, Catarina Gomes, Richard Karlsson, Catharina Steentoft, Charlotte B Spliid, Tobias Gustavsson, Ali Salanti, Andrea Persson,[...]. Nat Methods 2018
43
20

Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
Y Yang, C Gorzelanny, A T Bauer, N Halter, D Komljenovic, T Bäuerle, L Borsig, M Roblek, S W Schneider. Oncogene 2015
28
20

Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour.
John R Couchman, Sandeep Gopal, Hooi Ching Lim, Steffen Nørgaard, Hinke A B Multhaupt. Int J Exp Pathol 2015
52
20

Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.
Anurag Purushothaman, Douglas R Hurst, Claudio Pisano, Shuji Mizumoto, Kazuyuki Sugahara, Ralph D Sanderson. J Biol Chem 2011
77
20

Significance of host heparanase in promoting tumor growth and metastasis.
Gan-Lin Zhang, Lilach Gutter-Kapon, Neta Ilan, Tahira Batool, Kailash Singh, Andreas Digre, Zhengkang Luo, Stellan Sandler, Yuval Shaked, Ralph D Sanderson,[...]. Matrix Biol 2020
6
33

Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
Marina Weissmann, Gil Arvatz, Netanel Horowitz, Sari Feld, Inna Naroditsky, Yi Zhang, Mary Ng, Edward Hammond, Eviatar Nevo, Israel Vlodavsky,[...]. Proc Natl Acad Sci U S A 2016
69
20

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
Uri Barash, Moshe Lapidot, Yaniv Zohar, Cynthia Loomis, Andre Moreira, Sari Feld, Chandra Goparaju, Haining Yang, Edward Hammond, Ganlin Zhang,[...]. J Natl Cancer Inst 2018
23
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.